New York Community Bancorp’s stock falls to levels not seen since 1997

Date:

February 9, 2024

New York Community Bancorp. lost ground but remained above its 52-week intraday low as the hard-hit stock fell on Friday.

The stock
NYCB,
+6.56%
has lost about 60% of its value since announcing a surprise loss on Jan. 31 and then following up with a statement on its ‘ample’ liquidity and a new executive chairman on Wednesday.

Source link

LEAK: Biden's Private Tantrum After Hur Report Dropped

Pitch Deck Teardown: Xyte’s $30M Series A deck

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

New York Community Bancorp’s stock falls to levels not seen since 1997

Recent posts

Nvidia earnings send stock rocketing as company cheers AI ‘tipping point’

Toast’s stock heats up on sales jump

I’m 52 and retiring in 20 years. Should I invest in a Roth IRA or individual index funds like the Dow and Nasdaq?

Why Bank of Japan may shake up financial markets before Fed’s next interest-rate decision

2-year Treasury yield ends higher for 3rd straight week on signs of possible inflation trouble

Coach, Kate Spade parent reports revenue miss amid weakness in North America

Buffett praises ‘architect’ Munger, but doesn’t reveal new investment in Berkshire’s 2024 shareholder letter

Bet on battered IPOs, small caps and retail as rally broadens out, says trader who has been nailing some big calls

Cha-ching! How Trump is making $4 billion from his 2024 campaign for president.

Harvard remains the nation’s richest school as college endowments keep growing

Intuitive Machines’ stock takes a dive the day before planned moon landing

Jury finds Do Kwon and Terraform Labs liable for crypto fraud, in win for SEC

Nvidia’s earnings report could kill the momentum driving U.S. stocks higher, regardless of how it turns out.

‘Things have not been easy for us’: My sister is a hoarder and procrastinator. She is delaying probate of our parents’ estate. What can...

Viking Therapeutics faces higher bar for oral weight-loss drug after strong readout from rival

Related articles

Blink Charging’s CEO says drop in EV sales is mostly a Tesla problem

Subsidized internet and online-safety measures fail to make it into FAA bill

Ford plans to make Lucid and Waymo veteran its new CFO, as EV demand remains in flux

Why a less chaotic bond market could signal potential stock-buying opportunities

Democratic congressman warns crypto may become winning issue for GOP after Trump voices support

‘No return’ left for U.S. stock market in 2024, says Goldman’s David Kostin

Elon Musk says Tesla will spend ‘well over’ $500 million on new EV chargers

The feds are scrutinizing credit-card rewards. That could help frequent fliers get more out of their miles.

Company

Follow us